Acquired pure red cell aplasia [erythroblastopenia]

DOID MESH PheWeb

D3_ACQPUREREDCLLAPLASIA

No definition available.

Endpoint definition

↥

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 D60

Hospital discharge: ICD-9 2848C

Hospital discharge: ICD-8 28404

Cause of death: ICD-10 D60

Cause of death: ICD-9 2848C

Cause of death: ICD-8 28404

2 out of 7 registries used, show all original rules.

130

diagram downward connector

Check minimum number of events None

130

diagram downward connector

Include endpoints None

130

diagram downward connector

diagram downward connector

Remove individuals based on genotype QC

126

diagram downward connector

D3_ACQPUREREDCLLAPLASIA

Control definitions

Control exclude D3_APLASTICANDOTHANAEMIA

Extra metadata

Level in the ICD hierarchy 3

First used in FinnGen datafreeze DF2

Parent code in ICD-10 D60-D64

Name in latin Erythroblastopenia [pura] acquisita

NAME	D3_ACQPUREREDCLLAPLASIA
CONTROL_EXCLUDE	D3_APLASTICANDOTHANAEMIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D60
HD_ICD_9	2848C
HD_ICD_8	28404
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D60
COD_ICD_9	2848C
COD_ICD_8	28404
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Show upset plot detailing case counts by codes

Or the full data table

Similar endpoints

↥

List of similar endpoints to Acquired pure red cell aplasia [erythroblastopenia] based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	126	65	61
Unadjusted prevalence (%)	0.03	0.03	0.04
Mean age at first event (years)	55.84	50.83	61.16

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: D3_ACQPUREREDCLLAPLASIA – Acquired pure red cell aplasia [erythroblastopenia]
GWS hits:

Survival analyses between endpoints

↥

Plot

before Acquired pure red cell aplasia [erythroblastopenia]
after Acquired pure red cell aplasia [erythroblastopenia]

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Acquired pure red cell aplasia [erythroblastopenia]

↥

Endpoint not on priority list, no data to show.